Schedule 13D ownership disclosure

ITERUM THERAPEUTICS PLC SHS NEW

Security class unavailable · CUSIP: G6333L101

Event date: 2018-05-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001062993-18-002521
Form type
SC 13D
Filer
Advent Life Sciences LLP
CIK
CIK 1601364
Filed
Jun 11, 2018
Reporting period
May 30, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub